To mitigate the effects of the COVID-19 pandemic on incentives under the Federal Food, Drug, and Cosmetic Act for the development of orphan drugs, and for other purposes.
Health119-hr7693 — To mitigate the effects of the COVID-19 pandemic on incentives under the Federal Food, Drug, and Cosmetic Act for the development of orphan drugs, and for other purposes.. Sponsored by Rep. Gottheimer, Josh [D-NJ-5]. Introduced 2026-02-25. House bill. 119th Congress. Latest action: Referred to the House Committee on Energy and Commerce.
- Sponsor
- Rep. Gottheimer, Josh [D-NJ-5] (D), NJ
- Introduced
- 2026-02-25
- Committees
- Energy and Commerce Committee
- Latest Action
- Referred to the House Committee on Energy and Commerce.
No roll-call vote data available for this bill.
Similar Bills
- 119-hr7685 — To amend the Federal Food, Drug, and Cosmetic Act to specify that hair straightening or smoothing products containing formaldehyde or formaldehyde releasing substances will be considered adulterated, and for other purposes. 31% match
- 119-hr1843 — To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications. 31% match
- 118-hr7974 — To amend the Federal Food, Drug, and Cosmetic Act to require labeling of food products containing insects, and for other purposes. 30% match 118th Congress
- 118-hr7827 — To amend the Federal Food, Drug, and Cosmetic Act to encourage the development of vaccines to prevent, treat, or mitigate opioid, cocaine, methamphetamine, or alcohol use disorder, to establish an x-prize for the development of such a vaccine, and for other purposes. 27% match 118th Congress
- 119-hr2111 — To amend the Federal Food, Drug, and Cosmetic Act to exempt the premium cigar industry from certain regulations. 26% match
Investigate this bill →
Beneficiary scoring, topic classification, and fiscal analysis